Mar 5, 2026 04:16PM
Mar 5, 2026 04:15PM
Feb 17, 2026 08:05AM
Feb 11, 2026 08:45AM
Feb 11, 2026 08:45AM
Jan 5, 2026 06:41AM
Jan 2, 2026 07:02AM Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
Dec 31, 2025 04:15PM
Dec 31, 2025 04:15PM
Dec 19, 2025 08:05AM
Dec 19, 2025 08:05AM
Nov 13, 2025 08:31AM
Nov 13, 2025 08:30AM
Nov 3, 2025 08:35AM Outlook Therapeutics resubmits drug application to FDA after September meeting
Nov 3, 2025 08:35AM
Sep 30, 2025 06:54AM
Sep 29, 2025 04:03PM
Sep 29, 2025 08:45AM
Sep 29, 2025 08:45AM
Sep 2, 2025 08:35AM
Sep 2, 2025 08:35AM Outlook Therapeutics Requests Type A Meeting with FDA
Aug 29, 2025 06:51AM
Aug 28, 2025 06:53AM
Aug 28, 2025 06:30AM
Aug 14, 2025 08:05AM
Jul 24, 2025 09:00AM
Jul 22, 2025 08:45AM
Jul 1, 2025 08:06AM Outlook Therapeutics (OTLK) Appoints Bob Jahr as CEO
Jul 1, 2025 08:05AM
Jun 18, 2025 09:05AM
Jun 13, 2025 06:53AM
Jun 10, 2025 08:06AM
Jun 10, 2025 08:05AM
Jun 2, 2025 07:03AM
Jun 2, 2025 07:00AM Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
May 23, 2025 06:39AM
May 23, 2025 06:30AM
May 22, 2025 04:05PM
May 22, 2025 04:01PM
May 15, 2025 04:01PM
Apr 9, 2025 07:21AM
Apr 8, 2025 05:02PM Outlook Therapeutics (OTLK) Announces FDA Set August 27, 2025 as PDUFA for ONS-5010
Apr 8, 2025 08:45AM
Apr 8, 2025 08:45AM
Feb 28, 2025 08:05AM
Feb 28, 2025 08:05AM
Feb 19, 2025 09:00AM
Feb 18, 2025 06:44AM
Feb 14, 2025 08:05AM Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update
Feb 4, 2025 09:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All